The proteome company

Antigen Discovery Inc. provides research services and products specializing in high throughput protein microarray technology that simplifies proteomic biomarker discovery and enables serological and immune profiling of whole proteomes.

ADI’s powerful proteome microarray approach significantly decreases the time and cost required to perform proteome-wide antigen screening by eliminating time consuming steps in traditional cloning, protein expression and screening methodologies. ADI’s flexible and robust microarray platform facilitates the discovery of diagnostic biomarkers, vaccine candidates, as well as therapeutic antibody discovery and target validation.

Ph.D. in molecular biology from University of California San Diego/Salk Institute and Postdoctoral at University of California Berkeley. Executive training in Leadership and Strategy in Pharmaceuticals and Biotech, Harvard Business School. Lead Scientist of Bio-defense Division at Life Technologies Corporation. Senior research position at Vical, Inc.

B.S. degree in Business Administration and Finance from the University of California, Riverside. Management at CoreValve, Inc., a “start-up” medical device company acquired by Medtronic, Inc. Financial management positions including VP of Finance at CETI and NTD technologies. Corporate Controller at Thuris Corporation, a medical device and pharmaceutical company.

Ph.D. in Medicine from University of Barcelona & M.Sc. in Control of Infectious Diseases from London School of Hygiene & Tropical Medicine. Leadership roles in coordinating African laboratory and field teams for clinical trials at the Barcelona Center for Global Health Research. Preclinical and clinical vaccine development at Naval Medical Research Center.

Ph.D. in Molecular Biology at University of California, Los Angeles and Postdoctoral at the Salk Institute. Leadership roles in molecular biology, fermentation, GMP manufacturing, regulatory affairs, and vaccine development projects at Vical, Inc. Senior research and leadership roles at Epimmune and Cytel.

Ph.D. in Information and Computer Science from University of California, Irvine. Leadership roles in interdisciplinary research projects at the UCI Institute for Genomics and Bioinformatics. Bioinformatics Scientist at Applied Proteomics, Inc. Extensive experience in experimental design and biomarker discovery utilizing mass spectrometry and protein microarray data.